beta

You're viewing our new website - find out more

Publication - Consultation Paper

Review of Lung Cancer Quality Performance Indicators: consultation

Published: 14 Nov 2016
Part of:
Health and social care
ISBN:
9781786526007

A consultation on the revised Lung Cancer Quality Performance Indicators (QPIs), which were revised following a formal review.

40 page PDF

630.7kB

40 page PDF

630.7kB

Contents
Review of Lung Cancer Quality Performance Indicators: consultation
Contents Update Record

40 page PDF

630.7kB

Contents Update Record

October 2016 (v3.0)

This document was updated following formal review of the Lung Cancer Quality Performance Indicators ( QPIs) which took place following analysis of year 3 of the lung cancer QPI data.

The following QPIs have been updated:

  • QPI 2 - Pathological diagnosis
  • QPI 5 - Investigation of mediastinal malignancy
  • QPI 6 - Surgical resection in non small cell lung cancer
  • QPI 8 - Radiotherapy in inoperable lung cancer
  • QPI 11 - Systemic anti cancer therapy in non small cell lung cancer
  • QPI 13 - Mortality following treatment for lung cancer

The following QPIs have been archived:

  • QPI 3 - Bronchoscopy

The following new QPIs have been added:

  • QPI 14 - Stereotactic Ablative Body Radiotherapy ( SABR) in inoperable stage I non small cell lung cancer
  • QPI 15 - Pre-treatment diagnosis

Please note the extant Clinical Trials QPI has now been added into each tumour specific QPI document (see QPI 16: Clinical Trials).

As a result of the changes above, the contents page differ from earlier versions of this document. Sections 1 - 11 and the appendices have also been updated.

Please note that this version of the Lung Cancer QPI Document applies to cases diagnosed from 1st January 2016 onwards. Where amended or new QPIs require new data items for measurement, this will apply for patients diagnosed from 1st January 2017.

Previous Updates:

March 2015 (v2.1)

This document was updated following baseline review of the lung cancer QPIs which took place following analysis of year 1 of the lung cancer QPI data. As a result, the following QPIs have been updated:

  • QPI 2 - Pathological diagnosis
  • QPI 5 - Investigation of mediastinal malignancy
  • QPI 7 - Lymph node assessment
  • QPI 8 - Radiotherapy in inoperable lung cancer
  • QPI 9 - Chemoradiotherapy in locally advanced non small cell lung cancer
  • QPI 12 - Chemotherapy in small cell lung cancer
  • QPI 13 - Mortality following treatment for lung cancer

Please note that 2.1 version of the Lung Cancer QPI Document applies to cases diagnosed from 1st April 2014 onwards.

Please note that this document has been updated to include QPI 1 - Multi-Disciplinary Team ( MDT) Meeting.

The overall QPI numbering, contents page and the page numbering have been amended as a result and therefore differ from earlier versions of this document.


Contact